tiprankstipranks
Trending News
More News >

Eterna Therapeutics Implements 1-for-15 Reverse Stock Split

Story Highlights
Eterna Therapeutics Implements 1-for-15 Reverse Stock Split

Don’t Miss TipRanks’ Half-Year Sale

An update from Eterna Therapeutics ( (ERNA) ) is now available.

On June 12, 2025, Ernexa Therapeutics Inc. implemented a reverse stock split of its common stock at a ratio of 1-for-15 by filing a certificate of amendment with the Secretary of State of Delaware. This corporate action is likely aimed at consolidating shares to potentially enhance the company’s stock price and improve its market perception.

More about Eterna Therapeutics

Average Trading Volume: 360,017

Technical Sentiment Signal: Strong Sell

Current Market Cap: $9.67M

For a thorough assessment of ERNA stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1